A Genome-wide Association Study on the Endophenotype of Spatial Working Memory in ADHD
NCT ID: NCT02710929
Last Updated: 2021-09-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
232 participants
OBSERVATIONAL
2015-08-01
2018-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. To find the genetic variations associated with spatial working memory performance in patients with ADHD by using genome-wide association studies (GWAS);
2. To find the genetic variations associated with spatial working memory performance in healthy subjects by using GWAS;
3. To recruit a validation sample and to replicate the findings from the initial GWAS;
4. To test whether genetic variations significantly associated with spatial working memory are also associated with ADHD.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Endophenotype, Molecular Genetic Study on Attention-Deficit/Hyperactivity Disorder
NCT00529906
Investigation of the HDAC4 Copy Number Variation and Its Effect on Gene and Protein Expression in Patients With ASD
NCT03670381
Evaluating the Validity of a Genetic Risk Assessment Tool in Identifying Autism Spectrum Disorder
NCT01452061
A Family Study of Copy Number Variations in Patients With Autism Spectrum Disorder
NCT02228876
Expanding Rapid Ascertainment Networks of Schizophrenia Families in Taiwan
NCT01357005
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is a 3-year project. Our previous studies have collected blood samples and spatial working memory data of 382 patients with ADHD and 150 healthy subjects. In this 3-year project, we will recruit 232 healthy subjects, aged 7-18 years. The measures include (1) interviews for psychopathology (K-SADS-E), (2) questionnaires to measures ADHD symptoms (SNAP-IV), and (3) neuropsychological tests: Spatial Working Memory task of the CANTAB. In the first year, a case-only GWAS on spatial working memory (n = 254) will be conducted. In the second year, a control-only GWAS on spatial working memory (n = 254) will be conducted. In the third year, findings from the initial two GWAS will be replicated in a validation sample composed of 128 patients with ADHD and 128 healthy controls.
By careful calculation, a sample size of 382 ADHD subjects will provide adequate power to detect genome-wide significant genetic variations and replicate the findings in an independent validation sample. We anticipate to identify the relationship between genetic variations of ADHD and the endophenotype of spatial working memory. Our findings will significantly contribute to our understanding of the pathophysiological mechanisms of ADHD, especially the pathological pathway from genes, through endophenotype, to behavioral phenotypes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ADHD group
Subjects with clinical diagnosis of ADHD according to the DSM-IV criteria
No interventions assigned to this group
TD group
Typically development controls without lifetime diagnosis with ADHD
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
7 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chi-Yung Shang, MD
Role: PRINCIPAL_INVESTIGATOR
Dept of Psychiatry, National Taiwan University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Taiwan Univeristy Hospital
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201412157RINA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.